Jesper Mosolff Mathiesen

6.9k total citations · 2 hit papers
45 papers, 5.2k citations indexed

About

Jesper Mosolff Mathiesen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Jesper Mosolff Mathiesen has authored 45 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Jesper Mosolff Mathiesen's work include Receptor Mechanisms and Signaling (35 papers), Neuroscience and Neuropharmacology Research (13 papers) and Neuropeptides and Animal Physiology (12 papers). Jesper Mosolff Mathiesen is often cited by papers focused on Receptor Mechanisms and Signaling (35 papers), Neuroscience and Neuropharmacology Research (13 papers) and Neuropeptides and Animal Physiology (12 papers). Jesper Mosolff Mathiesen collaborates with scholars based in Denmark, United States and Germany. Jesper Mosolff Mathiesen's co-authors include Brian K. Kobilka, Tong Sun Kobilka, William I. Weis, Andrew C. Kruse, Foon Sun Thian, Roger K. Sunahara, Georgios Skiniotis, Jan Steyaert, Pil Seok Chae and Syed Tasadaque Ali Shah and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jesper Mosolff Mathiesen

43 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structure of the β2 adrenergic receptor–Gs protein complex

2011 2.4k citations Jesper Mosolff Mathiesen, Georgios Skiniotis et al. Nature profile →
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist

2012 1.1k citations Jesper Mosolff Mathiesen, Leonardo Pardo et al. Nature profile →

Peers

Countries citing papers authored by Jesper Mosolff Mathiesen

Since Specialization

Citations

This map shows the geographic impact of Jesper Mosolff Mathiesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Mosolff Mathiesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Mosolff Mathiesen more than expected).

Fields of papers citing papers by Jesper Mosolff Mathiesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Mosolff Mathiesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Mosolff Mathiesen. The network helps show where Jesper Mosolff Mathiesen may publish in the future.

Co-authorship network of co-authors of Jesper Mosolff Mathiesen

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Mosolff Mathiesen. A scholar is included among the top collaborators of Jesper Mosolff Mathiesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Mosolff Mathiesen. Jesper Mosolff Mathiesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue 2025 ·Journal of Medicinal Chemistry ·Henrik K. Munch, (unknown), Jesper Mosolff Mathiesen, Per‐Olof Eriksson, (unknown), (unknown), (unknown), Oliver Demmer, (unknown), Dieter Hamprecht, Wolfgang Rist, (unknown), Achim Grube, (unknown), Lise Giehm	2
2	Detailed functional characterization of four nanobodies as positive allosteric modulators of the human calcium-sensing receptor 2024 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), Hans Bräuner‐Osborne, Jesper Mosolff Mathiesen, Donald T. Ward, Anders A. Jensen	0
3	Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor 2024 ·Nature Structural & Molecular Biology ·Hossein Batebi, Guillermo Pérez‐Hernández, (unknown), (unknown), (unknown), (unknown), (unknown), Johanna K. S. Tiemann, Ramón Guixà-González, Franziska Reinhardt, Peter F. Stadler, Makaía M. Papasergi-Scott, Georgios Skiniotis, Patrick Scheerer, Brian K. Kobilka, Jesper Mosolff Mathiesen, Xiangyu Liu, Peter W. Hildebrand	10
4	A µ-opioid receptor modulator that works cooperatively with naloxone 2024 ·Nature ·Evan S. O’Brien, (unknown), Amal El Daibani, Shainnel O. Eans, (unknown), Elizabeth White, (unknown), Yuki Shiimura, Kaavya Krishna Kumar, (unknown), (unknown), Weijiao Huang, Chen‐Song Zhang, Brandon J. Kennedy, Jesper Mosolff Mathiesen, Tao Che, Jay P. McLaughlin, Susruta Majumdar, Brian K. Kobilka	18
5	Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats 2023 ·BMC Gastroenterology ·(unknown), Jesper Mosolff Mathiesen, Bjarne Due Larsen, Christian Thorkildsen, Yvette M. Petersen	6
6	Glycine: a long-sought novel ligand for GPR158 2023 ·Trends in Pharmacological Sciences ·Mette M. Rosenkilde, Jesper Mosolff Mathiesen	1
7	G-protein activation by a metabotropic glutamate receptor 2021 ·Nature ·Alpay B. Seven, Ximena Barros-Álvarez, (unknown), Makaía M. Papasergi-Scott, Michael J. Robertson, Chen‐Song Zhang, Robert M. Nwokonko, Yang Gao, Justin Meyerowitz, Jean‐Philippe Rocher, Dominik Schelshorn, Brian K. Kobilka, Jesper Mosolff Mathiesen, Georgios Skiniotis	99
8	Asymmetric activation of the calcium-sensing receptor homodimer 2021 ·Nature ·Yang Gao, Michael J. Robertson, (unknown), Alpay B. Seven, Chen‐Song Zhang, Justin Meyerowitz, Ouliana Panova, Fadil Hannan, Rajesh V. Thakker, Hans Bräuner‐Osborne, Jesper Mosolff Mathiesen, Georgios Skiniotis	86
9	Structures of metabotropic GABAB receptor 2020 ·Nature ·Makaía M. Papasergi-Scott, Michael J. Robertson, Alpay B. Seven, Ouliana Panova, Jesper Mosolff Mathiesen, Georgios Skiniotis	81
10	Structural insights into differences in G protein activation by family A and family B GPCRs 2020 ·Science ·Daniel Hilger, Kaavya Krishna Kumar, Hongli Hu, (unknown), Evan S. O’Brien, Lise Giehm, C. Jennings, Gözde Eskici, Asuka Inoue, Michael T. Lerch, Jesper Mosolff Mathiesen, Georgios Skiniotis, Brian K. Kobilka	96
11	Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells 2020 ·Scientific Reports ·Thor C. Møller, (unknown), Jeffrey R. van Senten, (unknown), Jesper Mosolff Mathiesen, Michel Bouvier, Hans Bräuner‐Osborne	44
12	Structural Insights into the Process of GPCR-G Protein Complex Formation 2019 ·Cell ·Xiangyu Liu, Xinyu Xu, Daniel Hilger, Philipp Aschauer, Johanna K. S. Tiemann, Yang Du, H Liu, Kunio Hirata, Xiaoou Sun, Ramón Guixà-González, Jesper Mosolff Mathiesen, Peter W. Hildebrand, Brian K. Kobilka	120
13	A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors 2015 ·SLAS DISCOVERY ·Line Vedel, Hans Bräuner‐Osborne, Jesper Mosolff Mathiesen	16
14	Real-time trafficking and signaling of the glucagon-like peptide-1 receptor 2013 ·Molecular and Cellular Endocrinology ·(unknown), Pernille Wismann, Christina Rye Underwood, Nikolaj Kulahin, Helle K. Iversen, (unknown), Lauge Schäffer, (unknown), Jacob Hecksher‐Sørensen, (unknown), Jesper Mosolff Mathiesen, Hans Bräuner‐Osborne, Jennifer L. Whistler, (unknown), Maria Waldhoer	125
15	A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity 2010 ·Bioorganic & Medicinal Chemistry ·Nathan Stanley, Mark R. Hutchinson, (unknown), Birgitte Nielsen, Jesper Mosolff Mathiesen, Hans Bräuner‐Osborne, Thomas D. Avery, Edward R. T. Tiekink, Daniel Sejer Pedersen, Rodney J. Irvine, Andrew D. Abell, Dennis K. Taylor	3
16	Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jean‐Marie Receveur, (unknown), Thomas M. Frimurer, Peter Aadal Nielsen, Jesper Mosolff Mathiesen, Thomas Högberg	11
17	Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Jean‐Marie Receveur, Thomas M. Frimurer, Trond Ulven, Jesper Mosolff Mathiesen, Evi Kostenis, Thomas Högberg	9
18	The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains Gαi and Downstream Signaling Cascade Activation 2008 ·Journal of Biological Chemistry ·R Schröder, Nicole Merten, Jesper Mosolff Mathiesen, Lene Martini, (unknown), (unknown), Andree Blaukat, Fang Ye, Elizabeth Tran, Trond Ulven, Christel Drewke, Jennifer L. Whistler, Leonardo Pardo, Jesús Gomeza, Evi Kostenis	48
19	The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation 2006 ·British Journal of Pharmacology ·Jesper Mosolff Mathiesen, (unknown)	27
20	Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2 2005 ·Molecular Pharmacology ·Jesper Mosolff Mathiesen, Trond Ulven, Lene Martini, Lars Ole Gerlach, Ákos Heinemann, Evi Kostenis	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact